fda_approval_header

Alzheimer’s and Parkinson’s diseases currently affect over 50 million people worldwide. Due to the rapid aging of the population, these diseases will reach epidemic proportions in the 21st century if no cure is found.

Clear Therapeutics is using a novel technology to develop drugs that will prevent and treat these diseases. The unique approach used by Clear is to target the brain pathology by clearing the brain of toxic protein aggregates that attack nerve cells and disrupt normal brain function.



Copyright © 2010 Clear Therapeutics, Inc.